Phase IB/II Study of Second-Line Therapy with Panitumumab, Irinotecan, and Everolimus (PIE) in KRAS Wild-Type Metastatic Colorectal Cancer.

Amanda Townsend, Niall Tebbutt, Christos Karapetis, Pamela Cooper, Nimit Singhal, Susan Yeend, Louise Pirc, Rohit Joshi, Jennifer Hardingham, Timothy Price

    Research output: Contribution to journalArticlepeer-review

    4 Citations (Scopus)

    Fingerprint

    Dive into the research topics of 'Phase IB/II Study of Second-Line Therapy with Panitumumab, Irinotecan, and Everolimus (PIE) in KRAS Wild-Type Metastatic Colorectal Cancer.'. Together they form a unique fingerprint.

    Medicine & Life Sciences